When Adam Feinberg tried to figure out how to synthesize human tissue four years ago, his supplies were prosaic: a kitchen blender, some gelatin packets from the supermarket baking aisle, and a $2,000 3D printer.
“I had no external funding when I started, so we did it kind of on the cheap,” said Feinberg, 38, a biomedical engineer who runs a
lab at Carnegie Mellon University in Pittsburgh.
In a paper published today in
Science Advances, Feinberg and his colleagues describe how they eventually refined the technique to print structural replicas of the tissue of arteries, brains, and other organs out of proteins like collagen and fibrin. While the forms they created aren't functioning organs with living cells, they could one day act as a scaffold on which to grow actual tissues.
Adam Feinberg's lab at Carnegie Mellon uses 3D printing to try to replicate human tissues.
Source: Carnegie Mellon University College of Engineering
Feinberg’s fundamental advance is figuring out how to keep the soft structures created by a modified MakerBot 3D printer from collapsing under their own weight. Unlike plastic, the normal material of a 3D printer, collagen won’t hold its shape as it is being synthesized unless it has some support.
The research team started thinking about how Jell-O molds can suspend pieces of fruit in a sugary gel. They experimented with gelatin, blending it into a slurry of fine particles. The slurry would support the structure being built, layer by layer, while still allowing the printer’s nozzle—modified with a syringe—to move freely. When the printed object is complete, it would hold together on its own, and the supporting gel could be melted away in water at body temperature.
Feinberg's lab modified an off-the-shelf MakerBot 3D printer to handle biological materials.
Source: Carnegie Mellon University College of Engineering
Cooking up tissues that can be implanted into patients remains a challenge for the future. “That’s going to happen eventually, but there’s still so much fundamental science to be done,” Angelini said.
In the near term, the new method of 3D printing might let doctors test medical treatments on laboratory replicas of patients' own body parts. Drug companies could use such models to test risky new drugs before they're used in humans.
"Right now we have animal models—mice and rats—and we have [human] clinical trials, and not a lot in between," Feinberg said. "You can potentially make basically a patient-specific piece of heart muscle."
Feinberg’s research was supported by grants from the National Institutes of Health and the National Science Foundation. But the shoestring strategy he started with, hacking an off-the-shelf printer and buying some gelatin packs, still informs how his lab works. Though Carnegie Mellon has applied for a patent on the support bath, his team is releasing information on how to modify the MakerBot printer to handle biological materials under open-source licenses. He has also demonstrated the bioprinting technique at a local school, using chocolate frosting instead of collagen.
“We think it’s a lot easier to use these less expensive machines,” Feinberg said. “We can essentially modify it any way we need to make it work.”
No comments:
Post a Comment